日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Bevacizumab-Insights from EudraVigilance Database on the Assessments of the Safety Profile of Monoclonal Antibodies Used as Targeted Cancer Treatment

贝伐珠单抗——来自EudraVigilance数据库的关于单克隆抗体作为靶向癌症治疗药物安全性评估的见解

Vonica, Razvan Constantin; Butuca, Anca; Morgovan, Claudiu; Pumnea, Manuela; Cipaian, Remus Calin; Frum, Adina; Dobrea, Carmen Maximiliana; Vonica-Tincu, Andreea Loredana; Pacnejer, Aliteia-Maria; Ghibu, Steliana; Batar, Florina; Gligor, Felicia Gabriela

Real-World Evidence of Bevacizumab and Panitumumab Drug Resistance and Drug Ineffectiveness from EudraVigilance Database

来自EudraVigilance数据库的贝伐珠单抗和帕尼单抗耐药性和药物无效性的真实世界证据

Vonica, Razvan Constantin; Morgovan, Claudiu; Butuca, Anca; Pumnea, Manuela; Cipaian, Remus Calin; Frum, Adina; Dobrea, Carmen Maximiliana; Vonica-Tincu, Andreea Loredana; Pacnejer, Aliteia-Maria; Batar, Florina; Vornicu, Vlad; Ghibu, Steliana; Gligor, Felicia Gabriela

Comparative Analysis of Neuropsychiatric Adverse Reactions Associated with Remdesivir and Nirmatrelvir/Ritonavir in COVID-19 Treatment: Insights from EudraVigilance Data

瑞德西韦与尼马替韦/利托那韦治疗 COVID-19 相关神经精神不良反应的比较分析:来自 EudraVigilance 数据的启示

Pacnejer, Aliteia-Maria; Negru, Mihaela Cristina; Arseniu, Anca Maria; Trandafirescu, Cristina; Oancea, Cristian; Gligor, Felicia Gabriela; Morgovan, Claudiu; Butuca, Anca; Dehelean, Cristina Adriana

Neuropsychiatric Burden of SARS-CoV-2: A Review of Its Physiopathology, Underlying Mechanisms, and Management Strategies

SARS-CoV-2 的神经精神负担:对其病理生理学、潜在机制和管理策略的综述

Pacnejer, Aliteia-Maria; Butuca, Anca; Dobrea, Carmen Maximiliana; Arseniu, Anca Maria; Frum, Adina; Gligor, Felicia Gabriela; Arseniu, Rares; Vonica, Razvan Constantin; Vonica-Tincu, Andreea Loredana; Oancea, Cristian; Mogosan, Cristina; Popa Ilie, Ioana Rada; Morgovan, Claudiu; Dehelean, Cristina Adriana